Universal Beteiligungs und Servicegesellschaft mbH cut its position in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 2.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 157,029 shares of the company's stock after selling 3,783 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.08% of Docusign worth $12,782,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. Choreo LLC grew its position in shares of Docusign by 17.9% in the 1st quarter. Choreo LLC now owns 7,041 shares of the company's stock worth $573,000 after buying an additional 1,068 shares during the last quarter. Horizon Investment Services LLC grew its holdings in Docusign by 351.3% during the first quarter. Horizon Investment Services LLC now owns 24,024 shares of the company's stock valued at $1,956,000 after purchasing an additional 18,701 shares during the period. Gallacher Capital Management LLC bought a new stake in Docusign during the first quarter valued at about $434,000. Los Angeles Capital Management LLC lifted its position in shares of Docusign by 113.9% in the first quarter. Los Angeles Capital Management LLC now owns 88,179 shares of the company's stock valued at $7,178,000 after acquiring an additional 46,958 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky lifted its position in shares of Docusign by 0.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 65,320 shares of the company's stock worth $5,317,000 after buying an additional 330 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors.
Docusign Price Performance
Docusign stock traded up $0.93 during midday trading on Monday, hitting $80.80. 333,164 shares of the stock were exchanged, compared to its average volume of 2,619,698. Docusign Inc. has a 1 year low of $48.80 and a 1 year high of $107.86. The firm has a market cap of $16.33 billion, a P/E ratio of 15.29, a P/E/G ratio of 29.81 and a beta of 1.08. The company has a 50 day moving average price of $80.18 and a two-hundred day moving average price of $82.99.
Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.09. The company had revenue of $763.65 million during the quarter, compared to analyst estimates of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The firm's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period last year, the business earned $0.82 EPS. As a group, analysts predict that Docusign Inc. will post 1.17 EPS for the current year.
Docusign announced that its board has approved a share repurchase program on Thursday, June 5th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 6.6% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board of directors believes its shares are undervalued.
Insider Buying and Selling at Docusign
In other Docusign news, CFO Blake Jeffrey Grayson sold 15,143 shares of the business's stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total transaction of $1,132,696.40. Following the completion of the transaction, the chief financial officer directly owned 110,723 shares of the company's stock, valued at $8,282,080.40. The trade was a 12.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Allan C. Thygesen sold 40,000 shares of the business's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the sale, the chief executive officer owned 143,983 shares in the company, valued at $11,160,122.33. This trade represents a 21.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 78,552 shares of company stock valued at $5,983,631. Corporate insiders own 1.66% of the company's stock.
Analyst Ratings Changes
A number of research analysts have recently commented on DOCU shares. UBS Group cut their target price on Docusign from $85.00 to $80.00 and set a "neutral" rating on the stock in a research note on Friday, June 6th. Hsbc Global Res upgraded Docusign from a "moderate sell" rating to a "hold" rating in a research note on Friday, April 11th. HSBC upgraded Docusign from a "reduce" rating to a "hold" rating and set a $70.00 target price on the stock in a research note on Friday, April 11th. Needham & Company LLC restated a "hold" rating on shares of Docusign in a research note on Friday, June 6th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $124.00 price objective on shares of Docusign in a report on Tuesday, June 3rd. Twelve investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Docusign has an average rating of "Hold" and a consensus price target of $89.77.
View Our Latest Research Report on Docusign
Docusign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.